SOURCES SOUGHT
B -- Survey of Acrylamide Levels in Food
- Notice Date
- 8/26/2002
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Division of Construction and Agency Support Contracting, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- Reference-Number-F63367
- Response Due
- 9/4/2002
- Point of Contact
- Hamilton Brown, Contract Specialist, Phone (301) 827-7043, Fax (301) 827-7101, - Hamilton Brown, Contract Specialist, Phone (301) 827-7043, Fax (301) 827-7101,
- E-Mail Address
-
hbrown@oc.fda.gov, hbrown@oc.fda.gov
- Description
- To more fully understand the occurrence of acrylamide in the food supply, FDA is testing foods in the U.S. market to determine the presence and levels of this chemical. This testing has two overall goals, estimating the exposure of U.S. consumers to acrylamide in food and gathering information on how different processing methods affect formation of acrylamide. As a first objective toward these goals, a survey across foods will be undertaken to determine the range of foods that contain detectable acrylamide. The second objective will be to estimate variability within and across food types so that more comprehensive sampling and monitoring plans can be designed. The Food and Drug Administration (FDA) intends to award a non-competitive, sole source contract to Covance Laboratories to perform approximately 400-500 analyses of food samples that will be gathered nationwide by FDA and shipped directly to Covance. The 400-500 sample analyses shall include method validation using standard approaches and samples provided by FDA. Following the method validation work, the food samples that FDA sends for analysis will be either commercially prepared products purchased at supermarkets throughout the country, ingredient commodities such as dried powdered milk products purchased at distributors, or composited samples of table-ready foods prepared for FDA's Total Diet Study. In addition, evaluation of method and product variation shall be undertaken through multiple sample composites and analyses using protocols to be determined by FDA. The contractor shall log in the following information to send to FDA with the results: sample number assigned by FDA, date and location of sampling (information provided by FDA with samples), names of the products, lot numbers/production codes and expiration dates (where applicable), and sampling portion where applicable (e.g., center or heel slice of bread, whole breaded fish fillet as packaged). The contractor shall take readable digital photographs of the ingredient list and bar code. The contractor shall use a method developed by FDA for analyzing the samples, and send FDA the results in a spreadsheet provided by FDA, including the following information: analytical results in ppb, sample size, serving size, and the information logged in when the samples were received. For commercially prepared products, the contractor shall use the serving size listed on the package as the sample size for homogenization. The contractor shall monitor three ions for confirmation, as described in the FDA method. The ion used for quantitation shall have a signal/noise (s/n) ratio of 10:1 or greater (s/n less than 10:1 for ion m/z 52) and the two ions used for confirmation shall have an s/n ratio of 3:1 or greater. The results shall be either a "non-detect" for samples below the limit of quantitation (LOQ) or a numerical value for samples above the LOQ. The LOQ shall be 30 ppb or better. Other parties interested in and capable of performing this work shall submit their capability statement on or before September 4, 2002.
- Place of Performance
- Address: Contractor site
- Record
- SN00149873-W 20020828/020826213222 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |